The Medication Affordability and Patent Integrity Act would create new regulatory burdens on biotech companies, making it harder and taking longer to develop new treatments, while doing nothing to lower prescription drug prices.
Politics
·
The wrong prescription for drug affordability
CN
CitrixNews Staff
Originally reported by The Hill. Read the full story at the original source.
Related Articles
Politics
Sean ‘Diddy’ Combs release date moved up, federal records show
Combs was sentenced in October to four years and two months in federal prison after being convicted of transporting peop...
CitrixNews Staff
·
58 minutes ago
Politics
Judge who attended Fani Willis campaign event recuses from DOJ voting lawsuit
A federal judge agreed to step aside on Monday from a major voting lawsuit brought by the Trump administration...
CitrixNews Staff
·
1 hour ago
Politics
ICE cannot be allowed to hide its death count
The reality is that ICE has a long track record of abusing detainees.
CitrixNews Staff
·
1 hour ago
Politics
COVID-19 vaccine linked with lower risk of heart attack, stroke: Study
The COVID-19 vaccine lowered the risk of cardiovascular issues associated with the virus by around 40 percent, according...
CitrixNews Staff
·
1 hour ago